iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Deepak Nitrite has received revision in credit ratings from ICRA for bank facilities worth Rs 490 crore and commercial paper of Rs 200 crore as under Long term rating – ICRA AA; Positive rating reaffirmed and outlook revised from Stable Short term rating – ICRA A1 The companys subsidiary Deepak Phenolics received upgrade in credit ratings for bank facilities worth Rs 75627 crore as under […]

image

Aarti Surfactants announced about fire incident that took place at its Silvassa plant on 19 March 2022 at around 0700 PM The fire is brought under control leaving no loss or injury to human life The Production disruption caused from the said fire will be recouped from another plant at Pithampur to a large extent

image

Future Supply Chain Solutions announced that an Extra Ordinary General Meeting EGM of the Company will be held on 20 April 2022

image

SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool to manufacture nirmatrelive an oral anti-viral COVID-19 medicine developed by Pfizer to increase broad access of treatment in 95 low- and mid-income countries

image

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 21 March 2022

image

Embassy Office Parks REIT Embassy REIT has received a green loan certification in respect of loan facilities amounting to Rs 730 crore raised from Axis Bank from Climate Bonds Initiative Embassy REIT is the first organization in the Indian real estate sector to receive a green loan certification from Climate Bonds Initiative an investor-focused international not-for-profit organization working to mobilize global capital for climate action […]

image

Alembic Pharmaceuticals announced that it has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Lacosamide Tablets USP 50 mg 100 mg 150 mg and 200 mg The approved ANDA is therapeutically equivalent to the reference listed drug product RLD Vimpat Tablets 50 mg 100 mg 150 mg and 200 mg of UCB Inc Lacosamide Tablets […]

image

Softrak Venture Investment will hold a meeting of the Board of Directors of the Company on 26 March 2022

image

Ceinsys Tech will hold a meeting of the Board of Directors of the Company on 26 March 2022

image

Future Retail announced that an Extra Ordinary General Meeting EGM of the Company will be held on 20 April 2022

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.